MiR-22 may Suppress Fibrogenesis by Targeting TGFβR i in Cardiac Fibroblasts

Cellular Physiology and Biochemistry

Volumn 40, Issue 6, 2016, Pages 1345-1353

  Hong, Yuan ^a   Cao, Huaming ^a   Wang, Qiang ^a   Ye, Jianlin ^a   Sui, Lijun ^b   Feng, Jinhua ^c   Cai, Xiaojun ^a   Song, Huizhu ^a   Zhang, Xiuhong ^a   Chen, Xichuang ^c  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Department of Internal Medicine ^*  (China)

^c SOOCHOW UNIVERSITY   (China)

Author keywords

Cardiac fibrosis; MicroRNA 22; Myocardial infarction; TGF RI

Indexed keywords

ANGIOTENSIN II; COLLAGEN TYPE 1; COLLAGEN TYPE 1 ALPHA 1; COLLAGEN TYPE 3; COLLAGEN TYPE 3 ALPHA 1; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; LIPOFECTAMINE; LUCIFERASE; MESSENGER RNA; MICRORNA 22; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; UNCLASSIFIED DRUG; COLLAGEN; MICRORNA; MIRN22 MICRORNA, MOUSE; MIRN22 MICRORNA, RAT; PROTEIN SERINE THREONINE KINASE; TGF-BETA TYPE I RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

3' UNTRANSLATED REGION; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CORONARY ARTERY LIGATION; CORONARY ARTERY OCCLUSION; DOWN REGULATION; EXPERIMENTAL FIBROSIS; EXPERIMENTAL MYOCARDIAL INFARCTION; FIBROGENESIS; GENETIC TRANSFECTION; HEART FIBROBLAST; HEART MUSCLE FIBROSIS; HISTOPATHOLOGY; IN VITRO STUDY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LUCIFERASE ASSAY; MALE; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; RAT; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CARDIAC MUSCLE; CELL CULTURE; DRUG EFFECTS; FIBROBLAST; FIBROSIS; GENE SILENCING; GENETICS; HEART INFARCTION; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANGIOTENSIN II; ANIMALS; BASE SEQUENCE; CELLS, CULTURED; COLLAGEN; DOWN-REGULATION; FIBROBLASTS; FIBROSIS; GENE SILENCING; MALE; MICE, INBRED C57BL; MICRORNAS; MYOCARDIAL INFARCTION; MYOCARDIUM; PROTEIN-SERINE-THREONINE KINASES; RATS, SPRAGUE-DAWLEY; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA;

EID: 85008659750     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000453187     Document Type: Article

References (31)

1. Roy S, Khanna S, Hussain SR, Biswas S, Azad A, Rink C, Gnyawali S, Shilo S, Nuovo GJ, Sen CK: MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. Cardiovasc Res 2009;82:21-29
2. Melchior-Becker A, Dai G, Ding Z, Schafer L, Schrader J, Young MF, Fischer JW: Deficiency of biglycan causes cardiac fibroblasts to differentiate into a myofibroblast phenotype. J Biol Chem 2011;286:17365-17375
3. Tillmanns J, Hoffmann D, Habbaba Y, Schmitto JD, Sedding D, Fraccarollo D, Galuppo P, Bauersachs J: Fibroblast activation protein alpha expression identifies activated fibroblasts after myocardial infarction. J Mol Cell Cardiol 2015;87:194-203
4. Thum T: Noncoding RNAs and myocardial fibrosis. Nat Rev Cardiol 2014;11:655-663
5. Yang JJ, Tao H, Deng ZY, Lu C, Li J: Non-coding RNA-mediated epigenetic regulation of liver fibrosis. Metabolism 2015;64:1386-1394
6. Pandit KV, Milosevic J: MicroRNA regulatory networks in idiopathic pulmonary fibrosis. Biochem Cell Biol 2015;93:129-137
7. Liang H, Zhang C, Ban T, Liu Y, Mei L, Piao X, Zhao D, Lu Y, Chu W, Yang B: A novel reciprocal loop between microRNA-21 and TGFβR III is involved in cardiac fibrosis. Int J Biochem Cell Biol 2012;44:2152-2160
8. van Rooij E, Sutherland LB, Thatcher JE, DiMaio JM, Naseem RH, Marshall WS, Hill JA, Olson EN: Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci USA 2008;105:13027-13032
9. Guo S, Bai R, Liu W, Zhao A, Zhao Z, Wang Y, Zhao W, Wang W: miR-22 inhibits osteosarcoma cell proliferation and migration by targeting HMGB1 and inhibiting HMGB1-mediated autophagy. Tumour Biol 2014;35:7025-7034
10. Liang H, Xu C, Pan Z, Zhang Y, Xu Z, Chen Y, Li T, Li X, Liu Y, Huangfu L, Lu Y, Zhang Z, Yang B, Gitau S, Shan H, Du Z: The antifibrotic effects and mechanisms of microRNA-26a action in idiopathic pulmonary fibrosis. Mol Ther 2014;22:1122-1133
11. Tao A, Song J, Lan T, Xu X, Kvietys P, Kao R, Martin C, Rui T: Cardiomyocyte-fibroblast interaction contributes to diabetic cardiomyopathy in mice: Role of HMGB1/TLR4/IL-33 axis. Biochim Biophys Acta 2015;185:22075-22085
12. Zhang Y, Huang XR, Wei LH, Chung AC, Yu CM, Lan HY: miR-29b as a therapeutic agent for angiotensin II-induced cardiac fibrosis by targeting TGF-β/Smad3 signaling. Mol Ther 2014;22:974-985
13. He Y, Huang C, Lin X, Li J: MicroRNA-29 family, a crucial therapeutic target for fibrosis diseases. Biochimie 2013;95:1355-1359
14. Melo SF, Fernandes T, Baraúna VG, Matos KC, Santos AA, Tucci PJ, Oliveira EM: Expression of MicroRNA-29 and Collagen in Cardiac Muscle after Swimming Training in Myocardial-Infarcted Rats. Cell Physiol Biochem 2014;33:657-669
15. Zhao X, Wang K, Liao Y, Zeng Q, Li Y, Hu F, Liu Y, Meng K, Qian C, Zhang Q, Guan H, Feng K, Zhou Y, Du Y, Chen Z: MicroRNA-101a inhibits cardiac fibrosis induced by hypoxia via targeting TGFβRI on cardiac fibroblasts. Cell Physiol Biochem 2015;35:213-226
16. Yin K, Zhao L, Feng D, Ma W, Liu Y, Wang Y, Liang J, Yang F, Bi C, Chen H, Li X, Lu Y, Cai B: Resveratrol Attenuated Low Ambient Temperature-Induced Myocardial Hypertrophy via Inhibiting Cardiomyocyte Apoptosis. Cell Physiol Biochem 2015;35:2451-2462
17. Cavarretta E, Condorelli G: miR-21 and cardiac fibrosis: another brick in the wall? Eur Heart J 2015;36:2139-2141
18. Dong S, Ma W, Hao B, Hu F, Yan L, Yan X, Wang Y, Chen Z, Wang Z: microRNA-21 promotes cardiac fibrosis and development of heart failure with preserved left ventricular ejection fraction by up-regulating Bcl-2. Int J Clin Exp Pathol 2014;7:565-574
19. Bauersachs J: miR-21: a central regulator of fibrosis not only in the broken heart. Cardiovasc Res 2012;96:227-229; discussion 230-223
20. Thum T, Gross C, Fiedler J, Fischer T, Kissler S, Bussen M, Galuppo P, Just S, Rottbauer W, Frantz S, Castoldi M, Soutschek J, Koteliansky V, Rosenwald A, Basson MA, Licht JD, Pena JT, Rouhanifard SH, Muckenthaler MU, Tuschl T, Martin G.R, Bauersachs J, Engelhardt S: MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 2008;456:980-984
21. Duisters RF, Tijsen AJ, Schroen B, Leenders JJ, Lentink V, van der Made I, Herias V, van Leeuwen RE, Schellings MW, Barenbrug P, Maessen JG, Heymans S, Pinto YM, Creemers EE: miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling. Circ Res 2009;104:170-178, 176p following 178
22. Kaur K, Vig S, Srivastava R, Mishra A, Singh VP, Srivastava AK, Datta M: Elevated Hepatic miR-22-3p Expression Impairs Gluconeogenesis by Silencing the Wnt-Responsive Transcription Factor Tcf7. Diabetes 2015;64:3659-3669
23. Huang ZP, Wang DZ: miR-22 in cardiac remodeling and disease. Trends Cardiovasc Med 2014;24:267-272
24. Ahmad HM, Muiwo P, Ramachandran SS, Pandey P, Gupta YK, Kumar L, Kulshreshtha R, Bhattacharya A: miR-22 regulates expression of oncogenic neuro-epithelial transforming gene 1, NET1. FEBS J 2014;28:13904-13919
25. Huang ZP, Chen J, Seok HY, Zhang Z, Kataoka M, Hu X, Wang DZ: MicroRNA-22 regulates cardiac hypertrophy and remodeling in response to stress. Circ Res 2013;112:1234-1243
26. Gurha P, Abreu-Goodger C, Wang T, Ramirez MO, Drumond AL, van Dongen S, Chen Y, Bartonicek N, Enright AJ, Lee B, Kelm RJ Jr, Reddy AK, Taffet GE, Bradley A, Wehrens XH, Entman ML, Rodriguez A: Targeted deletion of microRNA-22 promotes stress-induced cardiac dilation and contractile dysfunction. Circulation 2012;125:2751-2761
27. Gurha P, Wang T, Larimore AH, Sassi Y, Abreu-Goodger C, Ramirez MO, Reddy AK, Engelhardt S, Taffet GE, Wehrens XH, Entman ML, Rodriguez A: microRNA-22 promotes heart failure through coordinate suppression of PPAR/ERR-nuclear hormone receptor transcription. PLoS One 2013;8:e75882
28. Leask A: TGFbeta, cardiac fibroblasts, and the fibrotic response. Cardiovasc Res 2007;74:207-212
29. Gabbiani G: The myofibroblast in wound healing and fibrocontractive diseases. J Pathol 2003;200:500-503
30. Eckes B, Zigrino P, Kessler D, Holtkötter O, Shephard P, Mauch C, Krieg T: Fibroblast-matrix interactions in wound healing and fibrosis. Matrix Biol 2000;19:325-332
31. Tan SM, Zhang Y, Connelly KA, Gilbert RE, Kelly DJ: Targeted inhibition of activin receptor-like kinase 5 signaling attenuates cardiac dysfunction following myocardial infarction. Am J Physiol Heart Circ Physiol 2010;298:H1415-1425